Guru Ownership Trend
Guru Analysis for Climb Bio, Inc. (CLYM)
Climb Bio, Inc. (CLYM), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $8.97 M.
Top institutional holders include Steven Cohen and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bullish. This is evidenced by a $2 M net inflow during the quarter.
Recent activity highlights Steven Cohen who opened a new position. Conversely, Renaissance Technologies (RenTech) reduced exposure by 40.3%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Climb Bio, Inc. (CLYM)
Major holders include Steven Cohen ($2.87 M), Renaissance Technologies (RenTech) ($1.28 M). According to the latest reported data, 2 tracked investment managers collectively hold approximately 1.04 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $2 M, with 1 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited CLYM. The total reported sell value was $866,000.
Yes, 1 managers opened new positions in CLYM, and 0 increased their existing holdings. The total reported buy value was $2.87 M.